XML 37 R26.htm IDEA: XBRL DOCUMENT v3.25.0.1

SEGMENT INFORMATION (Tables)

3 Months Ended

Jan. 31, 2025

Segment Reporting [Abstract]

SCHEDULE OF SEGMENT INFORMATION

 SCHEDULE OF SEGMENT INFORMATION 

		2025				2024
		For the Three Months Ended January 31,
		2025				2024
Net loss:
Cancer Vaccines		$	(2,018	)		$	(1,756	)
CAR-T Therapeutics			(1,177	)			(1,525	)
Other			(18	)			(9	)
Total		$	(3,213	)		$	(3,290	)
Net income (loss)		$	(3,213	)		$	(3,290	)
Total operating costs and expenses		$	3,386			$	3,609
Less non-cash stock-based compensation			(1,055	)			(1,260	)
Operating costs and expenses excluding non-cash stock-based compensation		$	2,331			$	2,349
Operating costs and expenses excluding non-cash stock-based compensation expense:
Cancer Vaccines		$	1,467			$	1,213
CAR-T Therapeutics			848				1,128
Other			16				8
Total		$	2,331			$	2,349
Operating costs and expenses excluding non-cash share based compensation		$	2,331			$	2,349

		January 31, 2025				October 31, 2024
Total assets:
Cancer Vaccines		$	11,863			$	12,917
CAR-T Therapeutics			6,885				8,535
Other			158				139
Total		$	18,906			$	21,591
Total assets		$	18,906			$	21,591

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-25

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration